Filing Flows › Volitionrx (VNRX) › Q1 2026 › vs Q4 2025
Volitionrx (VNRX) Q1 2026 vs Q4 2025 (quarter over quarter)
Volitionrx's revenue rose $538K (+120%) from $447K in Q4 2025 to $985K in Q1 2026.
Volitionrx, Q1 2026: revenue $985K (+300% year over year), operating margin -543.0%, net loss $6.7M, operating cash flow −$5.3M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $985K | $447K | $538K | +120% |
| Net loss | $6.7M | $6.3M | $401K | +6% |
| Costs & expenses | $7.7M | $6.7M | $939K | +14% |
| Operating costs | $6.3M | $5.3M | $1.1M | +20% |
| Interest & other, net | $1.4M | $1.5M | −$130K | -9% |
| Research & development | $2.9M | $2.5M | $384K | +16% |
| Sales & marketing | $852K | $1.0M | −$150K | -15% |
| General & admin | $2.6M | $1.8M | $834K | +46% |
| Operating cash sources | $6.7M | $6.3M | $401K | +6% |
| Depreciation & amortization | $207K | $231K | −$23K | -10% |
| Share-based compensation | $225K | $0 | $225K | — |
| Working capital & other | $991K | $580K | $411K | +71% |
| Cash used in operations | $5.3M | $5.5M | −$212K | -4% |
| Net loss absorbed | $6.7M | $6.3M | $401K | +6% |
Questions
How much did Volitionrx's revenue grow quarter over quarter in Q1 2026?
Volitionrx's revenue rose $538K (+120%) from $447K in Q4 2025 to $985K in Q1 2026.